Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody – Arthritis Research & Therapy   Commentary on Twitter High mortality risk predictors in patients with anti-MDA5 dermatomyositis include:– rapidly progressive interstitial lung disease– anti-Ro52 antibody– age > 57 years(based on study of 126 MDA-5+ DM pts)https://t.co/JLGIgALUip […]

The post Cohort Study | Mortality risk in anti-MDA5 dermatomyositis linked to rapid ILD progression and anti-Ro52 antibody levels appeared first on Links Medicus.